Anthera Pharmaceuticals, Inc.
Seite 2 von 5 Neuester Beitrag: 24.04.21 23:43 | ||||
Eröffnet am: | 11.01.13 17:18 | von: Bäcker33 | Anzahl Beiträge: | 101 |
Neuester Beitrag: | 24.04.21 23:43 | von: Doreenwwlia | Leser gesamt: | 22.386 |
Forum: | Hot-Stocks | Leser heute: | 11 | |
Bewertet mit: | ||||
Seite: < 1 | | 3 | 4 | 5 > |
aber wie geht´s mit Anthera weiter ? wie sind denn so die Zukunftsaussichten? Kurstechnisch , wie auch mit Anthera selbst ?
danke
ich hab die schon ne Weile im Visier gehabt , heut komm ich heim von der Arbeit und nu das .... sooooo schade :-(
Source: PR Newswire (US)
HAYWARD, Calif., Feb. 10, 2015 /PRNewswire/ -- Anthera Pharmaceuticals (NASDAQ: ANTH) today announced that the company has received formal notification from the Nasdaq Stock Market ("Nasdaq"), indicating that the Company has regained compliance with Listing Rule 5450(b)(1)(A), which requires a minimum of $10,000,000 in stockholders' equity or maintaining a market value of $50,000,000 or greater for ten consecutive business days. Nasdaq has determined that Anthera has maintained market value of at least $50,000,000 for the last ten consecutive business days and as such, the Company has met alternative listing requirements for continued listing.
About Anthera Pharmaceuticals
Anthera Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing products to treat serious and life-threatening diseases, including systemic lupus erythematosus, IgA nephropathy, and exocrine pancreatic insufficiency due to cystic fibrosis.